THE DUBERSTEIN GROUP INC. for PFIZER INC.
What was lobbied
7 issue areas, each in the filer's own words, with who lobbied on it and where.
Taxation/Internal Revenue Code TAX
Comprehensive corporate tax reform, including international taxes, tax extenders, deferral, excess returns/base erosion, territorial systems, patent/innovation box.
| Lobbyist | Covered position, as disclosed |
|---|---|
| DANIEL P MEYER | — |
Health Issues HCR
Healthcare reform - Proposed legislation re this issue.
| Lobbyist | Covered position, as disclosed |
|---|---|
| STEVEN CHAMPLIN | — |
Consumer Issues/Safety/Products CSP
FDA fees - HR 2725, Food and Drug Administration Safety Over Sequestration Act of 2013.
| Lobbyist | Covered position, as disclosed |
|---|---|
| STEVEN CHAMPLIN | — |
| DANIEL P MEYER | — |
Trade (domestic/foreign) TRD
India treatment of intellectual property - Proposed legislation re this issue; Executive Branch action re this issue. Trans Pacific Partnership Agreement - Executive Branch action re this issue.
| Lobbyist | Covered position, as disclosed |
|---|---|
| STEVEN CHAMPLIN | — |
Medicare/Medicaid MMM
Impact of fiscal deficit issues, including Continuing Resolution and debt limit extension, on Medicare Part D and rebates - HJ Res, 59, Continuing Appropriations Resolution, 2014. Implementation of Patient Protection and Affordable Care Act.
| Lobbyist | Covered position, as disclosed |
|---|---|
| STEVEN CHAMPLIN | — |
| DANIEL P MEYER | — |
Budget/Appropriations BUD
Impact of debt limit talks on healthcare issues.
| Lobbyist | Covered position, as disclosed |
|---|---|
| DANIEL P MEYER | — |
Pharmacy PHA
Pharmaceutical issues, including track and trace legislation - HR 1919, Safeguarding America's Pharmaceuticals Act of 2013; S 957, Drug Supply Chain Security Act; HR 3204, Drug Quality and Security Act. Specialty drug tiers - HR 460, Patients' Access to Treatments Act of 2013.Regulation of compounded drugs - HR 3019, S.A.F.E. Compounded Drugs Act of 2013; S 959, Pharmaceutical Quality, Security, and Accountability Act; HR 3204, Drug Quality and Security Act.
| Lobbyist | Covered position, as disclosed |
|---|---|
| STEVEN CHAMPLIN | — |
| BRIAN GRIFFIN | — |
| DANIEL P MEYER | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.